Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ORTHOPEDIATRICS CORP.

(KIDS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

OrthoPediatrics : JMP Securities Adjusts OrthoPediatrics' Price Target to $77 From $70, Maintains Outperform Rating

08/06/2021 | 10:07am EST


ę MT Newswires 2021
All news about ORTHOPEDIATRICS CORP.
11/22OrthoPediatrics to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conf..
AQ
11/08ORTHOPEDIATRICS CORP : Regulation FD Disclosure, Financial Statements and Exhibits (form 8..
AQ
11/04ORTHOPEDIATRICS CORP : Entry into a Material Definitive Agreement, Change in Directors or ..
AQ
11/04ORTHOPEDIATRICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R..
AQ
11/03OrthoPediatrics Corp. Reports Third Quarter 2021 Financial Results - Form 8-K
PU
11/03OrthoPediatrics Corp. Reports Earnings Results for the Third Quarter and Nine Months En..
CI
11/03Orthopediatrics Corp. Provides Earnings Guidance for the Year Ending December 31, 2021
CI
11/03ORTHOPEDIATRICS : Q3 Earnings Snapshot
AQ
11/03Earnings Flash (KIDS) ORTHOPEDIATRICS Reports Q3 Loss $-0.15
MT
11/03Earnings Flash (KIDS) ORTHOPEDIATRICS Reports Q3 Revenue $25.1M
MT
More news
Analyst Recommendations on ORTHOPEDIATRICS CORP.
More recommendations
Financials (USD)
Sales 2021 98,0 M - -
Net income 2021 -23,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -47,9x
Yield 2021 -
Capitalization 1 122 M 1 122 M -
Capi. / Sales 2021 11,4x
Capi. / Sales 2022 9,40x
Nbr of Employees 116
Free-Float 69,9%
Chart ORTHOPEDIATRICS CORP.
Duration : Period :
OrthoPediatrics Corp. Technical Analysis Chart | KIDS | US68752L1008 | MarketScreener
Technical analysis trends ORTHOPEDIATRICS CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 57,02 $
Average target price 78,83 $
Spread / Average Target 38,3%
EPS Revisions
Managers and Directors
David R. Bailey President, Chief Executive Officer & Director
Fred L. Hite Director, Chief Operating & Financial Officer
Mark C. Throdahl Executive Chairman
Peter F. Armstrong Chief Medical Officer
Joel Batts Senior Vice President-Science & Technology
Sector and Competitors